Continuing La Fosse's expansion into new markets, they are delighted to announce the opening of a Life Sciences Division. Experienced recruiters Stephanie Murtagh and Leslie Reeves have joined La Fosse to lead the Life Sciences team as the function's Managing Director and Client Services Director respectively.

Both are highly-specialised consultants and leaders, with extensive industry expertise and a proven track record of developing and scaling teams at pace. Since joining La Fosse, they have recruited a strong team of experienced recruiters who have track records across a number of specialisms, including Global Pharma, Biotech, CROs and Medical Devices.

The Life Sciences sector is predicted to continue its rapid growth, with global R&D spend alone expected to reach $181 billion in 2022, compared to $156.7 billion in 2016, according to research by Deloitte. With two industry leaders leading the practice's development, La Fosse is well-poised to take advantage of this booming industry.

Stephanie Murtagh specialises in the competitive Clinical Operations and Regulatory Affairs markets, and will be focusing on Interim recruitment in DACH, The Benelux, UK and US. In her previous role, she established a global Life Sciences Practice, bringing it from concept to a major market player.

Stephanie said: “I was attracted to La Fosse's ambitious growth plans and extensive client-base in the Venture Capital and Private Equity markets. As Global MD of the Life Sciences team, I look forward to scaling my team to provide exceptional service to clients in the UK and abroad."

Leslie Reeves, who joins as Global Client Services Director, specialises in Immuno Oncology and CAR-T. In his 10 years working within Life Sciences recruitment, he has led large successful teams, and has been the highest billing consultant in three agencies.

He commented: “La Fosse is well-known for its great brand and collegiate culture, which are major assets when scaling teams, from both a client and talent attraction perspective. It’s an ambitious but caring company, and the right environment for us to build an exceptional practice in our area of specialism.”

CEO James Parker added: "As a high-growth industry founded on innovation, Life Sciences shares many characteristics with our core markets. Building out this capability will also allow us to better support to our Private Equity and Venture Capital clients. We are delighted to have Stephanie and Leslie onboard, and I look forward to building a world-class offering together."

SOURCE: PR